Incidence Of Surgery For Inflammatory Bowel Disease Within 12 Months Of Initiation Of Vedolizumab Or Infliximab
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.1412
https://www.valueinhealthjournal.com/article/S1098-3015(17)31746-1/fulltext
Title :
Incidence Of Surgery For Inflammatory Bowel Disease Within 12 Months Of Initiation Of Vedolizumab Or Infliximab
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31746-1&doi=10.1016/j.jval.2017.08.1412
First page :
A632
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1265